First Patient Dosed Achieves Complete Response in Estrella Immunopharma's Trial for ... - CGTLive®

Retrieved on: 2024-10-03 19:27:35

Tags for this article:

Lymphoma

CAR T cell

Non-Hodgkin lymphoma

Kite Pharma

Adoptive cell transfer

Estrella Immunopharma Inc.

Click the tags to see associated articles and topics

First Patient Dosed Achieves Complete Response in Estrella Immunopharma's Trial for ... - CGTLive®. View article details on hiswai:

Summary

The article discusses Estrella Immunopharma's innovative approach in biopharma, using ARTEMIS T-cell therapy against B-cell lymphomas, achieving promising safety and efficacy. It connects to tags like CAR T cell, Kite Pharma, and lymphoma.

Article found on: www.cgtlive.com

View Original Article